维普中文期刊产品整合服务
250篇 您的检索式:作者名="TARNOW L"
    题名 作者 年代 出处 被引量
1Serum adiponection predicts all-cause mortality and end stage renal disease in patients with type 1 diabetes and diabetic nephropathy显示文摘Jorsal A Tarnow L Frystyk J 2008Kidney lnt2008,74,5:1
2Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy显示文摘Sato A Tarnow L Parving HH 1998Diabetes Care1998,21,9:1
3Association between mannose-binding lectin and vascular complications in Type 1 dia- betes显示文摘TK Hansen Tarnow L Thiel S et oZ 2004Scandinavian Journal Of Immunology2004,59,6:1
4YKL-40,a marker of inflammation and endothelial dysfunction,is elevated in patients with type 1 diabetes and increases with levels of albuminuria显示文摘Rathcke CN Persson F Tarnow L 2009Diabetes Care2009,32,2:1
5Genetics and hypertension 显示文摘Ellervik C Tarnow L Pedersen EB 2009Ugeskr Laeger2009,171,24:1
6Tubular and glomerular injury in diabetes and the impact of ACE inhibition显示文摘Nielsen SE Sugaya T Tarnow L 0,,09:1
7Serum uric acid as a predictor 显示文摘HOVIND P ROSSING P TARNOW L 2009Diabetes2009,,58:1
8Impact of metformin versus repaglinide on non-glyeaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes 显示文摘Lund SS Tarnow L Stehouwer CD 2008Eur J E ndocrinol2008,158,5:1
9Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate显示文摘Astrup AS Tarnow L Pietraszek L 2008Diabetes Care2008,31,6:1
10Increased serum adiponectin levels in type 1 diabetic patients with mierovascular complications 显示文摘Frystyk J Tarnow L Krarup H T 2005Diabetologia2005,48,9:1
11Time course of the antiproteinuric and antihypertensive effect of losartaa in diabotic nephropathy 显示文摘Andersen S Jacobsen P Tarnow L 2003Nephrol Dial Transplant2003,18,2:1
12Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes显示文摘Tarnow L Hovind P Teerlink T 2004Diabetes Care2004,27,3:1
13Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study显示文摘Hovind P Rossing P Tarnow L 2009Diabetes2009,58,7:1
14Mannose-binding lectin and mortality in type 2 diabetes显示文摘Hansen TK Gall MA Tarnow L 2006Archives of internal medicine2006,166,18:1
15Man- nose-Binding Lectin as a Predictor of Microal buminuria in Type 1 Diabetes An Inception Cohort Study显示文摘Hovind P Hansen TK Tarnow L 2005Dia- betes2005,54,5:1
16Plasminogen activator inhibitor-I and apolipoprotein E gene polymorphisms and diabetic angiopathy显示文摘Tarnow L Stehouwer CD Emeis JJ 2000Nephrol Dial Transplant2000,15,5:1
17Progression of diabetic nephropathy显示文摘 Rossing P Tarnow L 2001Kidney Int2001,59,2:1
18Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study 显示文摘Hovind P Tarnow L Rossing P 2004BMJ2004,328,7448:1
19Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications显示文摘Frystyk J Tarnow L Hansen TK 0,,:1
20Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial显示文摘Lund SS Tarnow L Frandsen M 2009Bri Med J2009,339,:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费